Ryan Specialty Holdings Inc. (NYSE:RYAN) Shares Purchased by State of Alaska Department of Revenue

State of Alaska Department of Revenue increased its position in shares of Ryan Specialty Holdings Inc. (NYSE:RYAN) by 2.8% during the first quarter, Holdings Channel.com reports. The fund owned 12,465 shares of the company’s stock after acquiring an additional 335 shares during the quarter. State of Alaska Department of Revenue’s holdings in Ryan Specialty were worth $920,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently modified their holdings of the company. Vanguard Group Inc. boosted its holdings in shares of Ryan Specialty by 5.7% during the fourth quarter. Vanguard Group Inc. now owns 9,880,504 shares of the company’s stock worth $633,933,000 after purchasing an additional 529,631 shares during the period. Bessemer Group Inc. boosted its holdings in Ryan Specialty by 2.5% during the fourth quarter. Bessemer Group Inc. now owns 3,283,216 shares of the company’s stock valued at $210,651,000 after purchasing an additional 79,976 shares in the last quarter. Blair William & Co. IL grew its holdings in shares of Ryan Specialty by 0.6% in the 4th quarter. Blair William & Co. IL now owns 2,765,963 shares of the company’s stock worth $177,464,000 after purchasing an additional 16,540 shares during the last quarter. Geode Capital Management LLC increased its holdings in Ryan Specialty by 2.7% during the 4th quarter. Geode Capital Management LLC now owns 1,799,130 shares of the company’s stock valued at $115,468,000 after purchasing an additional 46,960 shares in the last quarter. Finally, Barclays PLC lifted its position in shares of Ryan Specialty by 3.0% during the fourth quarter. Barclays PLC now owns 1,690,279 shares of the company’s stock worth $108,449,000 after purchasing an additional 48,536 shares in the last quarter. Institutional investors and hedge funds own 84.82% of the company’s stock.

Ryan Specialty Stock Performance

Shares of RYAN stock opened at $67.30 on Friday. The company has a current ratio of 1.05, a quick ratio of 1.05 and a debt-to-equity ratio of 3.45. Ryan Specialty Holdings Inc. has a 12 month low of $55.67 and a 12 month high of $77.16. The business’s 50-day moving average price is $68.28 and its 200-day moving average price is $68.07. The firm has a market capitalization of $17.66 billion, a price-to-earnings ratio of 197.95, a PEG ratio of 1.79 and a beta of 0.70.

Ryan Specialty (NYSE:RYAN) last released its earnings results on Thursday, May 1st. The company reported $0.39 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.39. The business had revenue of $690.17 million for the quarter, compared to analyst estimates of $680.80 million. Ryan Specialty had a net margin of 6.97% and a return on equity of 47.70%. Ryan Specialty’s revenue for the quarter was up 25.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.35 earnings per share. Equities research analysts forecast that Ryan Specialty Holdings Inc. will post 2.29 EPS for the current year.

Ryan Specialty Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, May 27th. Shareholders of record on Tuesday, May 13th were paid a dividend of $0.12 per share. The ex-dividend date of this dividend was Tuesday, May 13th. This represents a $0.48 dividend on an annualized basis and a yield of 0.71%. Ryan Specialty’s dividend payout ratio (DPR) is currently 141.18%.

Analysts Set New Price Targets

RYAN has been the topic of several analyst reports. Barclays cut their price objective on shares of Ryan Specialty from $88.00 to $83.00 and set an “overweight” rating on the stock in a report on Friday, April 11th. TD Cowen started coverage on shares of Ryan Specialty in a research note on Thursday, April 10th. They issued a “buy” rating and a $89.00 price target on the stock. Keefe, Bruyette & Woods lowered their price objective on shares of Ryan Specialty from $76.00 to $75.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 9th. Morgan Stanley boosted their price objective on Ryan Specialty from $78.00 to $80.00 and gave the stock an “overweight” rating in a report on Monday, May 19th. Finally, Wells Fargo & Company dropped their price target on shares of Ryan Specialty from $69.00 to $66.00 and set an “equal weight” rating for the company in a research report on Thursday, April 10th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and eight have given a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $75.58.

Insiders Place Their Bets

In other news, Director David P. Bolger sold 5,000 shares of Ryan Specialty stock in a transaction on Tuesday, June 3rd. The stock was sold at an average price of $70.80, for a total value of $354,000.00. Following the completion of the transaction, the director now directly owns 71,467 shares in the company, valued at approximately $5,059,863.60. The trade was a 6.54% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Mark Stephen Katz sold 14,377 shares of the stock in a transaction on Friday, June 13th. The stock was sold at an average price of $65.84, for a total value of $946,581.68. Following the completion of the sale, the executive vice president now owns 1,117 shares in the company, valued at $73,543.28. This trade represents a 92.79% decrease in their position. The disclosure for this sale can be found here. 52.21% of the stock is currently owned by insiders.

Ryan Specialty Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.